Literature DB >> 299793

Jejunoileal bypass for the treatment of massive obesity. Prevalence, morbidity, and short- and long-term consequences.

F L Iber, M Copper.   

Abstract

The jejunoileal bypass for patients 125 lb or more above their ideal body weight as an experimental procedure exchnages almost certain weight loss for many known and many yet undescribed problems. Study of the known complications has led to altered operative procedures and management techniques that lessen the impact of nearly all of the complications. All patients need occasional advice on potential complications, and most experience episodes of depletions or diarrhea that require hospital intervention. The improved versions of this surgery have not been present sufficiently long to indicate the real nature of long term changes, and careful evaluation is essential for at least small groups of these patients in order for all interested physicians to provide proper advice to the 10,000 or so patients who have already had this procedure. Careful selection of patients to identify those who will accept follow-up and seek help when needed, and to identify those with sufficient social adaptability to adjust to a change in body image, and a competent, experienced acute and chronic team for management lead to the majority of patients having a very satisfactory result. Many specific complications of massive obesity are specifically helped by this procedure. In America, this is the only treatment effective more than half of the time in the massively obese.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299793     DOI: 10.1093/ajcn/30.1.4

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years.

Authors:  Matías Sepúlveda; Munir Alamo; Yudith Preiss; Juan P Valderas
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

2.  The history of metabolic surgery for morbid obesity and a commentary.

Authors:  H Buchwald; R D Rucker
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

Review 3.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

4.  A prospective comparison of the jejunoileal and gastric bypass operations for morbid obesity.

Authors:  J A Buckwalter
Journal:  World J Surg       Date:  1977-11       Impact factor: 3.352

Review 5.  Open-surgery management of morbid obesity: old experience-new techniques.

Authors:  Bernhard Husemann
Journal:  Langenbecks Arch Surg       Date:  2003-11-04       Impact factor: 3.445

6.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  Rectal hyperplasia after jejunoileal bypass for morbid obesity.

Authors:  G V Appleton; E E Wheeler; R Al-Mufti; D N Challacombe; R C Williamson
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.